From December 31, 2023 to March 30, 2024, the company has repurchased 194,000 shares, representing 1.01% for $9 million. With this, the company has completed the repurchase of 7,617,925 shares, representing 34.21% for $650.74 million under the buyback announced on December 8, 2015.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
48.86 USD | -0.02% | +4.85% | -8.84% |
May. 07 | DA Davidson Adjusts Price Target on USANA Health Sciences to $46 From $48, Maintains Neutral Rating | MT |
May. 01 | Transcript : USANA Health Sciences, Inc., Q1 2024 Earnings Call, May 01, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-8.84% | 931M | |
+11.97% | 8.05B | |
+8.98% | 7.96B | |
+3.48% | 6.12B | |
-5.68% | 3.73B | |
-12.16% | 3.51B | |
-13.23% | 1.19B | |
-26.34% | 1.12B | |
+13.13% | 975M | |
-13.68% | 828M |
- Stock Market
- Equities
- USNA Stock
- News USANA Health Sciences, Inc.
- Tranche Update on USANA Health Sciences, Inc.'s Equity Buyback Plan announced on December 8, 2015.